Quick Search 
Drugs of Today
Register or sign in

  
 
  
Drugs Today 2019, 55(9): 587
ISSN 1699-3993
Copyright 2019 Clarivate Analytics
CCC: 1699-3993
DOI: 10.1358/dot.2019.55.9.3020159
 
 
The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis
Plachouri, K.-M., Chourdakis, V., Georgiou, S.
 
 
Generalized pustular psoriasis (GPP) is a severe psoriasis form that can be refractory to several systemic treatments. The role of interleukin (IL)-17/ T-helper 17 (Th17) axis inhibitors in the therapy of GPP is not fully established. The objective of this paper is to summarize the existing information on the efficacy and safety of secukinumab, ixekizumab and brodalumab in GPP. Articles published in the English language and derived from the databases MEDLINE (PubMed), Embase and Scopus were assessed for this study. Although the existing data on the potential therapeutic benefit of these agents in the treatment of GPP are encouraging, further studies are needed so as to provide sufficient evidence for their use in this serious condition.


Full Text: PDF 
 
  



© Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy